Probiotics as emerging adjuncts in metabolic associated fatty liver disease therapy-a systemic review.
- 2026-02-03
- Systematic Review
- BMC gastroenterology 26(1)
- Radha Samyuktha Reddy Narem
- Vani Mathakala
- Sri Tejaswi Sallabathula
- Vijaya Lakshmi Peddiboyina
- Uma Maheswari Devi Palempalli
- PubMed: 41634593
- DOI: 10.1186/s12876-026-04618-7
- High evidence
Lactobacillus and Bifidobacterium species were shown to regulate lipid metabolism, normalize liver enzyme activity, reduce insulin resistance, and attenuate hepatic inflammation.
- Effect
- Beneficial
- Effect size
- Moderate